Literature DB >> 32024597

Excess body weight, cigarette smoking, and type II diabetes incidence in the national FINRISK studies.

Neil Mehta1, Sari Stenholm2, Satu Männistö3, Pekka Jousilahti3, Irma Elo4.   

Abstract

PURPOSE: We identify the individual and joint contributions of excess weight and cigarette smoking to national-level type II diabetes (T2D) incidence and to educational and gender disparities therein filling an important gap in T2D epidemiology.
METHODS: Based on the FINRISK surveys conducted in 1997, 2002, and 2007 and linked to the Finnish National Drug Reimbursement Register through 2011, we used a regression-counterfactual approach to estimate the percentage of diagnosed drug-treated incident T2D cases attributable to excess body weight and cigarette smoking. Body mass index (BMI) and waist circumference were evaluated.
RESULTS: T2D incidence was 10.24 in men and 7.04 in women per 1000 person-years. Excess baseline BMI (≥25.0 kg/m2) explained 69% and 63%, and smoking explained 9% and 14% of T2D incidence, in men and women, respectively. Most of the gender difference was explained by the risk factors. Approximately 90% in men and 98% in women of the higher T2D incidence among those in the lower versus upper third of the educational distribution was explained by excess BMI. The results were similar for waist circumference and lifetime maximum BMI.
CONCLUSIONS: Excess body weight is the main risk factor contributing to national-level T2D incidence and disparities by educational attainment and gender in a high-income population.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cigarette smoking; Diabetes; Finland; Obesity; Population attributable risk fractions

Mesh:

Year:  2020        PMID: 32024597      PMCID: PMC7231607          DOI: 10.1016/j.annepidem.2019.12.008

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  29 in total

1.  Secular trends and educational differences in the incidence of type 2 diabetes in Finland, 1972-2007.

Authors:  Marian Abouzeid; Katja Wikström; Markku Peltonen; Jaana Lindström; Katja Borodulin; Ossi Rahkonen; Tiina Laatikainen
Journal:  Eur J Epidemiol       Date:  2015-04-03       Impact factor: 8.082

2.  Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality.

Authors:  Yang Hu; Geng Zong; Gang Liu; Molin Wang; Bernard Rosner; An Pan; Walter C Willett; JoAnn E Manson; Frank B Hu; Qi Sun
Journal:  N Engl J Med       Date:  2018-08-16       Impact factor: 91.245

3.  Maximum likelihood estimation of the attributable fraction from logistic models.

Authors:  S Greenland; K Drescher
Journal:  Biometrics       Date:  1993-09       Impact factor: 2.571

4.  The Contribution of Weight Status to Black-White Differences in Mortality.

Authors:  Irma T Elo; Neil Mehta; Samuel Preston
Journal:  Biodemography Soc Biol       Date:  2017

5.  Validation of self reported smoking by serum cotinine measurement in a community-based study.

Authors:  E Vartiainen; T Seppälä; P Lillsunde; P Puska
Journal:  J Epidemiol Community Health       Date:  2002-03       Impact factor: 3.710

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  Weight histories and mortality among finnish adults: the role of duration and peak body mass index.

Authors:  Neil K Mehta; Sari Stenholm; Irma T Elo; Arpo Aromaa; Markku Heliövaara; Seppo Koskinen
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

9.  Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations.

Authors:  Annemieke M W Spijkerman; Daphne L van der A; Peter M Nilsson; Eva Ardanaz; Diana Gavrila; Antonio Agudo; Larraitz Arriola; Beverley Balkau; Joline W Beulens; Heiner Boeing; Blandine de Lauzon-Guillain; Guy Fagherazzi; Edith J M Feskens; Paul W Franks; Sara Grioni; José María Huerta; Rudolf Kaaks; Timothy J Key; Kim Overvad; Domenico Palli; Salvatore Panico; M Luisa Redondo; Olov Rolandsson; Nina Roswall; Carlotta Sacerdote; María-José Sánchez; Matthias B Schulze; Nadia Slimani; Birgit Teucher; Anne Tjonneland; Rosario Tumino; Yvonne T van der Schouw; Claudia Langenberg; Stephen J Sharp; Nita G Forouhi; Elio Riboli; Nicholas J Wareham
Journal:  Diabetes Care       Date:  2014-10-21       Impact factor: 19.112

10.  International Differences in the Risk of Death from Smoking and Obesity: The Case of the United States and Finland.

Authors:  Neil Mehta; Irma Elo; Sari Stenholm; Arpo Aromaa; Markku Heliövaara; Seppo Koskinen
Journal:  SSM Popul Health       Date:  2017-12
View more
  1 in total

1.  A longitudinal follow-up study of a type 2 diabetes "lost to follow-up" cohort - positive effect on glycaemic control after changes in medication.

Authors:  Timo Kauppila; Merja K Laine; Mikko Honkasalo; Marko Raina; Johan G Eriksson
Journal:  Int J Circumpolar Health       Date:  2020-01-01       Impact factor: 1.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.